Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Shares Outstanding (Weighted Average) (2021 - 2025)

Historic Shares Outstanding (Weighted Average) for Bioventus (BVS) over the last 5 years, with Q3 2025 value amounting to $66.9 million.

  • Bioventus' Shares Outstanding (Weighted Average) rose 255.33% to $66.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.9 million, marking a year-over-year increase of 255.33%. This contributed to the annual value of $64.5 million for FY2024, which is 303.27% up from last year.
  • Bioventus' Shares Outstanding (Weighted Average) amounted to $66.9 million in Q3 2025, which was up 255.33% from $66.5 million recorded in Q2 2025.
  • Over the past 5 years, Bioventus' Shares Outstanding (Weighted Average) peaked at $66.9 million during Q3 2025, and registered a low of $41.8 million during Q2 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $59.1 million, with a median of $62.6 million in 2023.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 4741.35% in 2022, then soared by 175.02% in 2023.
  • Over the past 5 years, Bioventus' Shares Outstanding (Weighted Average) (Quarter) stood at $45.5 million in 2021, then surged by 35.0% to $61.4 million in 2022, then rose by 2.05% to $62.6 million in 2023, then rose by 3.03% to $64.5 million in 2024, then rose by 3.68% to $66.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $66.9 million for Q3 2025, versus $66.5 million for Q2 2025 and $66.0 million for Q1 2025.